Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics Haloperidol for psychosis-induced aggression or agitation A Cochrane review has been published on the use of haloperidol for rapid tranquilisation of psychosis-induced aggression or agitation. For more information click here. BNF palliative care section updated […]
Latest articles
The Liverpool Care Pathway – are patients suffering unnecessarily due to media criticism?
The overwhelming majority (89%) of senior palliative care doctors who responded to a survey carried out for the BMJ and Channel 4’s Dispatches think the Liverpool care pathway (LCP) is the right approach for caring for patients in their final hours, and they would choose it for themselves. However, almost three quarters (74%) think […]
SHORTCUTS
Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Ryan NM, Birring SS, Gibson PG. This study is the first double-blind, placebo-controlled RCT to investigate gabapentin for the treatment of refractory chronic cough. In it, 62 adults with refractory chronic cough of over 2 months, who did not have active respiratory disease, were […]
Proposal for the development of community end of Life Care: A guest post by Julian Abel
Background Over the last 45 years the hospice movement has set the standard for caring for people who are approaching the end of life. The levels of services have been developing steadily and the quality of care has been of the highest standard. An unintentional consequence of the development of end of life services […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Latest additions PCF updated monographs The online Palliative Care Formulary (PCF) is being continually updated. The following monographs have been updated during November 2012 and supersede those in the publication of the 4th edition of the Palliative Care […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Suboxone SL tablets replaced by SL film in US Sublingual (SL) combination tablets containing buprenorphine and naloxone (Suboxone®; Reckitt Benckiser, Warren, NJ, USA), are being replaced by a sublingual film in the US. The […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics EMA review of cardiovascular safety of NSAIDs The European Medicines Agency (EMA) has finalised a review of recently published information on the cardiovascular safety of non-steroidal anti-inflammatory drugs (NSAIDs). The review confirms the findings […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Latest additions PDF version of PCF4+ now available! An e-book PDF version containing the latest content of the on-line Palliative Care Formulary as of September 2012 (designated PCF4+) is now available to purchase and download from […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Hydromorphone ER 32mg launched in US A once daily modified-release hydromorphone 32mg tablet (Exalgo; Mallinckrodt, Hazelwood, MO) has been added to the existing product range of 8mg, 12mg and 16mg modified-release tablets for opioid-tolerant […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates FDA warn of skin injury with OTC rubefacients Rare cases of serious burns on the skin have been reported to the US Food and Drug Administration (FDA) where over-the-counter (OTC) topical muscle and joint […]